These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35546906)

  • 1. Discovery of a novel phosphoinositide 3-kinase gamma (PI3Kγ) inhibitor against hematologic malignancies and theoretical studies on its PI3Kγ-specific binding mechanisms.
    Zhu J; Ke K; Xu L; Jin J
    RSC Adv; 2019 Jun; 9(35):20207-20215. PubMed ID: 35546906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel selective PI3Kγ inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation.
    Zhu J; Li K; Xu L; Cai Y; Chen Y; Zhao X; Li H; Huang G; Jin J
    J Adv Res; 2022 Feb; 36():1-13. PubMed ID: 35127160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation into the anti-airway inflammatory role of the PI3Kγ inhibitor JN-PK1: An in vitro and in vivo study.
    Xiong W; Jia L; Liang J; Cai Y; Chen Y; Nie Y; Jin J; Zhu J
    Int Immunopharmacol; 2022 Oct; 111():109102. PubMed ID: 35964410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a Naïve Bayesian Classification Model with PI3Kγ structural features for virtual screening against PI3Kγ: Combining molecular docking and pharmacophore based on multiple PI3Kγ conformations.
    Jiang Y; Xiong W; Jia L; Xu L; Cai Y; Chen Y; Jin J; Gao M; Zhu J
    Eur J Med Chem; 2022 Dec; 244():114824. PubMed ID: 36257282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational Design of Novel Phosphoinositide 3-Kinase Gamma (PI3Kγ) Selective Inhibitors: A Computational Investigation Integrating 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.
    Li K; Zhu J; Xu L; Jin J
    Chem Biodivers; 2019 Jul; 16(7):e1900105. PubMed ID: 31111650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational study reveals substituted benzimidazole derivatives' binding selectivity to PI3Kδ and PI3Kγ.
    Zhang NN; Bai X; Zhao SS; Zheng XM; Tang L; Yang SG; Zhang JQ
    J Mol Model; 2022 Apr; 28(5):123. PubMed ID: 35438328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting phosphatidylinositol 3-kinase gamma (PI3Kγ): Discovery and development of its selective inhibitors.
    Zhu J; Li K; Yu L; Chen Y; Cai Y; Jin J; Hou T
    Med Res Rev; 2021 May; 41(3):1599-1621. PubMed ID: 33300614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-silico & In-vitro Identification of Structure-Activity Relationship Pattern of Serpentine & Gallic Acid Targeting PI3Kγ as Potential Anticancer Target.
    Sharma P; Shukla A; Kalani K; Dubey V; Luqman S; Srivastava SK; Khan F
    Curr Cancer Drug Targets; 2017; 17(8):722-734. PubMed ID: 28359246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
    Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
    Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the selective mechanism of phosphoinositide 3-kinase γ with benzothiazole and thiazolopiperidine γ-specific inhibitors by in silico approaches.
    Zhu J; Li K; Xu L; Jin J
    Chem Biol Drug Des; 2019 May; 93(5):818-831. PubMed ID: 30582283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3Kγ/AKT Signaling in High Molecular Weight Hyaluronan (HMWH)-Induced Anti-Hyperalgesia and Reversal of Nociceptor Sensitization.
    Bonet IJM; Khomula EV; Araldi D; Green PG; Levine JD
    J Neurosci; 2021 Oct; 41(40):8414-8426. PubMed ID: 34417329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of some flavonoids for inhibitory mechanism against cancer target phosphatidylinositol 3-kinase (PI3K) using computational tool.
    Suhail M; AlZahrani WM; Shakil S; Tarique M; Tabrez S; Zughaibi TA; Rehan M
    Front Pharmacol; 2023; 14():1236173. PubMed ID: 37900167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring PI3Kγ binding preference with Eganelisib, Duvelisib, and Idelalisib via energetic, pharmacophore and dissociation pathway analyses.
    Jia L; Wang L; Jiang Y; Xu L; Cai Y; Chen Y; Jin J; Sun H; Zhu J
    Comput Biol Med; 2022 Aug; 147():105642. PubMed ID: 35635904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Potent and Selective PI3Kγ Inhibitors.
    Drew SL; Thomas-Tran R; Beatty JW; Fournier J; Lawson KV; Miles DH; Mata G; Sharif EU; Yan X; Mailyan AK; Ginn E; Chen J; Wong K; Soni D; Dhanota P; Chen PY; Shaqfeh SG; Meleza C; Pham AT; Chen A; Zhao X; Banuelos J; Jin L; Schindler U; Walters MJ; Young SW; Walker NP; Leleti MR; Powers JP; Jeffrey JL
    J Med Chem; 2020 Oct; 63(19):11235-11257. PubMed ID: 32865410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different inhibition of Gβγ-stimulated class IB phosphoinositide 3-kinase (PI3K) variants by a monoclonal antibody. Specific function of p101 as a Gβγ-dependent regulator of PI3Kγ enzymatic activity.
    Shymanets A; Prajwal ; Vadas O; Czupalla C; LoPiccolo J; Brenowitz M; Ghigo A; Hirsch E; Krause E; Wetzker R; Williams RL; Harteneck C; Nürnberg B
    Biochem J; 2015 Jul; 469(1):59-69. PubMed ID: 26173259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kγ mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells.
    Zhang HW; Hu JJ; Fu RQ; Liu X; Zhang YH; Li J; Liu L; Li YN; Deng Q; Luo QS; Ouyang Q; Gao N
    Sci Rep; 2018 Jul; 8(1):11255. PubMed ID: 30050147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing Small Molecule PI3Kγ Inhibitors: A Review of Structure-Based Methods and Computational Approaches.
    Yin X; Wang J; Ge M; Feng X; Zhang G
    J Med Chem; 2024 Jul; 67(13):10530-10547. PubMed ID: 38988222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent discovery of phosphoinositide 3-kinase γ inhibitors for the treatment of immune diseases and cancers.
    Qiu X; Tian Y; Liang Z; Sun Y; Li Z; Bian J
    Future Med Chem; 2019 Aug; 11(16):2151-2169. PubMed ID: 31538525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p87 and p101 subunits are distinct regulators determining class IB phosphoinositide 3-kinase (PI3K) specificity.
    Shymanets A; Prajwal ; Bucher K; Beer-Hammer S; Harteneck C; Nürnberg B
    J Biol Chem; 2013 Oct; 288(43):31059-68. PubMed ID: 24014027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of phosphoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice.
    Siragusa M; Katare R; Meloni M; Damilano F; Hirsch E; Emanueli C; Madeddu P
    Circ Res; 2010 Mar; 106(4):757-68. PubMed ID: 20056919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.